Drugs for Neglected Diseases Part 2

Future Science Ltd, August 2011, Pages: 126

This is Part 2 of two Special Focus Issues of the peer-reviewed journal Future Medicinal Chemistry, guest-edited by Dr Takushi Kaneko of the Global Alliance for TB Drug Development (TB Alliance).

The two part series provides a forward-looking overview of current issues, challenges and significant advances in the discovery, design and development of bioactive agents, as well as target identification, for the treatment neglected diseases.

“The articles published over these two special issues provide valuable insights into the current contributions of medicinal chemistry efforts to neglected disease research”, said Dr Kaneko.

A range of international experts from industry and academia have contributed to the issues, which include Editorials, Perspectives, Reviews and Original Research. Interviews with James McKerrow (University of California) and Solomon Nwaka (World Health Organization) also feature.

All articles published across the two issues will remain free-to-access until the end of 2011.

FOREWORD
- Drugs for neglected diseases: part II
Takushi Kaneko

EDITORIAL
- The importance of patent sharing in neglected disease drug discovery
Chris Edlin

NEWS & ANALYSIS
- News & Analysis

- Interview with Solomon Nwaka
Solomon Nwaka

RESEARCH ARTICLE
- Diarylquinolines, synthesis pathways and quantitative structure–activity relationship studies leading to the discovery of TMC207
Jerome Guillemont, et al.

SPECIAL REPORT
- Drugs for Neglected Diseases initiative model of drug development for neglected diseases: current status and future challenges
Jean-Robert Ioset, Shing Chang

PERSPECTIVE
- Challenges and opportunities in developing novel drugs for TB
Takushi Kaneko, Christopher Cooper, Khisimuzi Mdluli

- Challenges in antimalarial drug discovery
Jeremy N Burrows, et al.

REVIEW
- Drug repositioning in the treatment of malaria and TB
Alexis Nzila, Zhenkun Ma, Kelly Chibale

- Nitroimidazoles for the treatment of TB: past, present and future
Tathagata Mukherjee, Helena Boshoff

ACKNOWLEDGEMENTS

Product Samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

• Drugs for Neglected Diseases Part 1
• Tuberculosis Therapeutics - Global Strategic Business Report
• Overview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa
• Evolving Patterns and Unmet Needs in the TB Population in Developing and Developed Markets
• Competitor Analysis: Tuberculosis Vaccines and Therapeutics
• Special Report: Evolving Patterns and Unmet Needs in the TB Population in Developing and Developed Markets
• Chemoinformatics: Directions Toward Combating Neglected Diseases
• The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine
• Nitric Oxide - Therapeutics, Markets and Companies
• PAREXEL Biopharmaceutical R&D Statistical Sourcebook 2012/2013